FDA DEVICE FACTS
Foundation Dermal Regeneration Scaffold Plus (DRS+) Solo
Bionova Medical, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Foundation DRS+ Solo is indicated for the management of wounds including: Full thickness and partial thickness wounds Pressure ulcers Venous ulcers Ulcers caused by mixed vascular etiologies Diabetic ulcers First degree burns Partial thickness burns (superficial second-degree burns) Donor sites and other bleeding surface wounds Abrasions Trauma wounds (abrasions, lacerations, skin tears) Dehisced wounds Surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence) Foundation DRS+ Solo may be cut to size.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。